European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Human medicines European public assessment report (EPAR): Amvuttra, vutrisiran, Date of authorisation: 15/09/2022, Revision: 6, Status: Authorised

Submitted by Anonymous (not verified) on 9 September 2026 - 16:32

Human medicines European public assessment report (EPAR): Amvuttra, vutrisiran, Date of authorisation: 15/09/2022, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Perjeta, pertuzumab, Date of authorisation: 04/03/2013, Revision: 27, Status: Authorised

Submitted by Anonymous (not verified) on 9 September 2026 - 16:08

Human medicines European public assessment report (EPAR): Perjeta, pertuzumab, Date of authorisation: 04/03/2013, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR): Zilbrysq, zilucoplan, Date of authorisation: 01/12/2023, Revision: 6, Status: Authorised

Submitted by Anonymous (not verified) on 9 September 2026 - 15:55

Human medicines European public assessment report (EPAR): Zilbrysq, zilucoplan, Date of authorisation: 01/12/2023, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Zercepac, trastuzumab, Date of authorisation: 27/07/2020, Revision: 16, Status: Authorised

Submitted by Anonymous (not verified) on 9 September 2026 - 15:52

Human medicines European public assessment report (EPAR): Zercepac, trastuzumab, Date of authorisation: 27/07/2020, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Colchicine Agepha Pharma, colchicine, Date of authorisation: 24/07/2026, Status: Authorised

Submitted by Anonymous (not verified) on 9 September 2026 - 15:50

Human medicines European public assessment report (EPAR): Colchicine Agepha Pharma, colchicine, Date of authorisation: 24/07/2026, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness